CLINICAL_TRIALS
trial_result
· 2019-08-09
Clinical Trial Update: A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD [Phase 4]
Summary
Phase 4 trial update reporting efficacy and safety of NVA237 in moderate to severe COPD, completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-08-09